Sarah Louise Durica, | |
11900 Bournefield Way Ste 140, Silver Spring, MD 20904-7822 | |
(540) 798-0724 | |
Not Available |
Full Name | Sarah Louise Durica |
---|---|
Gender | Female |
Speciality | Behavior Technician |
Location | 11900 Bournefield Way Ste 140, Silver Spring, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003535493 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Sarah Louise Durica, 8715 1st Ave Apt 402d, Silver Spring, MD 20910-3533 Ph: (540) 798-0724 | Sarah Louise Durica, 11900 Bournefield Way Ste 140, Silver Spring, MD 20904-7822 Ph: (540) 798-0724 |
News Archive
For the first time in its history, the United States will have a unified National HIV/AIDS Strategy. The plan released today outlines goals and an agenda to address the HIV epidemic in the U.S. This afternoon, administration officials will brief the public on the main features of the strategy.
Osteoporosis particularly affects elderly women: the bone's structure weakens and the risk of suffering fractures rises.
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc., announced today that it has obtained exclusive rights from the California Institute of Technology to inventions made in the laboratory of David Baltimore, Ph.D. covering methods and compositions for modulating microRNA-146 and microRNA-155.
An $8.3-million federal grant to The University of Texas M. D. Anderson Cancer Center Science Park - Research Division addresses the complex interplay between such varied factors as genetics, diet, and environmental exposure to toxins that cause cancer, asthma, diabetes, cardiovascular and other diseases.
› Verified 8 days ago